Moneycontrol

Budget 2023Budget 2023
Register Now : Nifty Banker 3.0 | India's First Retail Index Traders Online Conference.
Budget 2023
Budget 2023
you are here: HomeNewsTrends

COVAX faces shortfall of 190 million doses, India’s 'terrible surge’ severely hits supply

In a joint statement, WHO, UNICEF, GAVI and CEPI has said India's virus has hit COVAX’s supply and it will be short of 190 million doses by the end of June

May 28, 2021 / 10:34 AM IST
Representative Image )(Source: Shutterstock)

Representative Image )(Source: Shutterstock)

The “terrible" surge of the coronavirus cases in India has severely impacted COVAX’s vaccine supply in the second quarter of this year to the extent that there will be a shortfall of 190 million doses by the end of June, according to a joint statement by the WHO, UNICEF, GAVI and CEPI.

The joint statement was issued on Thursday by Coalition for Epidemic Preparedness Innovations (CEPI) CEO Dr Richard Hatchett, Gavi, the Vaccine Alliance CEO Dr Seth Berkley, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus and UNICEF Executive Director Henrietta Fore.

“Countries that are advanced in their vaccination programmes are seeing cases of COVID-19 decline, hospitalisations decrease and early signs of some kind of normality resume. However, the global picture is far more concerning,” the statement said.

Giving a call to action to equip COVAX to deliver 2 billion doses in 2021, the statement said, “we are seeing the traumatic effects of the terrible surge of COVID-19 in South Asia – a surge which has also severely impacted global vaccine supplies.”